Genmab Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and European Hematology Association (EHA) Congress : vimarsana.com

Media ReleaseCOPENHAGEN, Denmark; May 25, 2023 Oral presentations will highlight epcoritamab-bysp in combination with rituximab-lenalidomide in high-risk follicular lymphomaPoster presentations... | May 25, 2023

Related Keywords

Japan , United States , New Jersey , Germany , Copenhagen , Køavn , Denmark , Tokyo , Lugano , Ticino , Switzerland , Netherlands , Chicago , Illinois , American , Judith Klimovsky , David Freundel , Andrew Carlsen , Kalvebod Brygge , Twitter , American Society Of Clinical Oncology , Meeting Library , Product Communications , Exchange Commission , Access Library , Ministry Of Health , Abbvie Biotechnology Ltd , European Medicines Agency , International Conference On Malignant Lymphoma , European Hematology Association , Clinical Oncology , Annual Meeting , Hematology Association , Executive Vice President , Chief Development Officer , International Conference , Malignant Lymphoma , World Evidence , Marketing Authorization Application , European Medicines , Release Syndrome , Effector Cell , Associated Neurotoxicity Syndrome , Prescribing Information , Medication Guide , Senior Director , Vice President , Media Release , Annual Report , Y Shaped Genmab , Abbvie Biotechnology , Genmabas Stock Exchange , News , Nformation , Ress Release , Edia , Ay , 023 , Ral , Resentations , Ill , Ighlight , N , Ombination , Ith , Follicular , Ymphomaposter Gmab Dk0010272202 ,